Further, improved 5 year DFS and OS were observed in pathological tumor size <2 cm (91.1% and 96.9%), node negativity (92% and 96.2%), ER/PR positivity HER2 negativity (91.6% and 96.1%),. Here, ERBB2 is linked to neoplasm.